These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23119236)

  • 21. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M; Mahmoodzadeh M; Farrahi F
    AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel.
    Dholakia M; Thakkar V; Patel N; Gandhi T
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S42-5. PubMed ID: 23066202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
    Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
    PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system.
    Abraham S; Furtado S; Bharath S; Basavaraj BV; Deveswaran R; Madhavan V
    Pak J Pharm Sci; 2009 Apr; 22(2):175-9. PubMed ID: 19339228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
    Balasubramaniam J; Pandit JK
    Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Moxifloxacin Hydrochloride loaded
    Swain GP; Patel S; Gandhi J; Shah P
    J Oral Biol Craniofac Res; 2019; 9(3):190-200. PubMed ID: 31080718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate.
    Gupta S; Vyas SP
    Sci Pharm; 2010; 78(4):959-76. PubMed ID: 21179328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system.
    Kesavan K; Nath G; Pandit J
    Daru; 2010; 18(4):237-46. PubMed ID: 22615622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.
    Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M
    Gels; 2022 Oct; 8(11):. PubMed ID: 36354595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Approach for Dry Eye Management By Mucoadhesive In situ Gel of Vitamin B12: Formulation, In vitro and In vivo Assessment.
    Mohamad SA; Alaaeldin E; Abdallah RMA; Mansour HF
    AAPS PharmSciTech; 2021 Mar; 22(3):87. PubMed ID: 33665761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of in situ gel of pregabalin.
    Madan JR; Adokar BR; Dua K
    Int J Pharm Investig; 2015; 5(4):226-33. PubMed ID: 26682193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation.
    Bhandwalkar MJ; Avachat AM
    AAPS PharmSciTech; 2013 Mar; 14(1):101-10. PubMed ID: 23229381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting on
    Al Gawhari FJ
    J Adv Pharm Technol Res; 2023; 14(4):294-298. PubMed ID: 38107457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
    Sultana Y; Aqil M; Ali A; Zafar S
    Pharm Dev Technol; 2006; 11(3):313-9. PubMed ID: 16895842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels.
    Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS
    Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
    Gupta H; Velpandian T; Jain S
    J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.
    Kotreka UK; Davis VL; Adeyeye MC
    PLoS One; 2017; 12(2):e0172306. PubMed ID: 28222100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization,
    Khan FU; Nasir F; Iqbal Z; Neau S; Khan I; Hassan M; Iqbal M; Ullah A; Khan SI; Sakhi M
    Iran J Pharm Res; 2021; 20(3):592-608. PubMed ID: 34904011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.